Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John J Ko

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Journal of Managed Care & Specialty Pharmacy|July 25, 2017
Real-World Adherence and Persistence to Oral Disease-Modifying Therapies in Multiple Sclerosis Patients Over 1 YearKristen M Johnson, Huanxue Zhou, Feng Lin, et al.
Journal of Medical Internet Research|November 1, 2018
The Impact of Disease-Modifying Therapy Access Barriers on People With Multiple Sclerosis: Mixed-Methods StudyKristina F Simacek, John J Ko, Debbie Moreton, et al.
BMC Neurology|September 30, 2016
Persistency, medication prescribing patterns, and medical resource use associated with multiple sclerosis patients receiving oral disease-modifying therapies: a retrospective medical record reviewTara Nazareth, Howard S Friedman, Prakash Navaratnam, et al.
Journal of Managed Care & Specialty Pharmacy|September 26, 2017
Outcomes-Based Contracting Experience: Research Findings from U.S. and European StakeholdersTara Nazareth, John J Ko, Rahul Sasane, et al.
Orphanet Journal of Rare Diseases|April 27, 2021
Patient and caregiver experiences of living with acute hepatic porphyria in the UK: a mixed-methods studyLiz Gill, Sue Burrell, John Chamberlayne, et al.
Journal of Managed Care & Specialty Pharmacy|March 28, 2019
The Impact of Price Reductions After Loss of Exclusivity in a Cost-Effectiveness Analysis: Fingolimod Versus Interferon Beta-1a for the Treatment of Relapsing-Remitting Multiple SclerosisLe H Hua, Carrie M Hersh, Peter Morten, et al.
Journal of Managed Care & Specialty Pharmacy|March 26, 2016
Analysis of Glycemic Control of a Pharmacist-Led Medication Management Program in Patients with Type 2 DiabetesJohn J Ko, Jackie Lu, Karen Rascati, et al.
Plos One|August 21, 2020
Correction: Detecting rare diseases in electronic health records using machine learning and knowledge engineering: Case study of acute hepatic porphyriaAaron M Cohen, Steven Chamberlin, Thomas Deloughery, et al.
Plos One|July 3, 2020
Detecting rare diseases in electronic health records using machine learning and knowledge engineering: Case study of acute hepatic porphyriaAaron M Cohen, Steven Chamberlin, Thomas Deloughery, et al.
Advances in Therapy|July 30, 2022
Patient Perspective on Acute Hepatic Porphyria with Sporadic Attacks: A Chronic Disease with Substantial Health-Related Quality of Life ImpactsKristen Wheeden, Desiree Lyon Howe, Sue Burrell, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Journal of Managed Care & Specialty Pharmacy|July 25, 2017
Real-World Adherence and Persistence to Oral Disease-Modifying Therapies in Multiple Sclerosis Patients Over 1 YearKristen M Johnson, Huanxue Zhou, Feng Lin, et al.
Journal of Medical Internet Research|November 1, 2018
The Impact of Disease-Modifying Therapy Access Barriers on People With Multiple Sclerosis: Mixed-Methods StudyKristina F Simacek, John J Ko, Debbie Moreton, et al.
BMC Neurology|September 30, 2016
Persistency, medication prescribing patterns, and medical resource use associated with multiple sclerosis patients receiving oral disease-modifying therapies: a retrospective medical record reviewTara Nazareth, Howard S Friedman, Prakash Navaratnam, et al.
Journal of Managed Care & Specialty Pharmacy|September 26, 2017
Outcomes-Based Contracting Experience: Research Findings from U.S. and European StakeholdersTara Nazareth, John J Ko, Rahul Sasane, et al.
Orphanet Journal of Rare Diseases|April 27, 2021
Patient and caregiver experiences of living with acute hepatic porphyria in the UK: a mixed-methods studyLiz Gill, Sue Burrell, John Chamberlayne, et al.
Journal of Managed Care & Specialty Pharmacy|March 28, 2019
The Impact of Price Reductions After Loss of Exclusivity in a Cost-Effectiveness Analysis: Fingolimod Versus Interferon Beta-1a for the Treatment of Relapsing-Remitting Multiple SclerosisLe H Hua, Carrie M Hersh, Peter Morten, et al.
Journal of Managed Care & Specialty Pharmacy|March 26, 2016
Analysis of Glycemic Control of a Pharmacist-Led Medication Management Program in Patients with Type 2 DiabetesJohn J Ko, Jackie Lu, Karen Rascati, et al.
Plos One|August 21, 2020
Correction: Detecting rare diseases in electronic health records using machine learning and knowledge engineering: Case study of acute hepatic porphyriaAaron M Cohen, Steven Chamberlin, Thomas Deloughery, et al.
Plos One|July 3, 2020
Detecting rare diseases in electronic health records using machine learning and knowledge engineering: Case study of acute hepatic porphyriaAaron M Cohen, Steven Chamberlin, Thomas Deloughery, et al.
Advances in Therapy|July 30, 2022
Patient Perspective on Acute Hepatic Porphyria with Sporadic Attacks: A Chronic Disease with Substantial Health-Related Quality of Life ImpactsKristen Wheeden, Desiree Lyon Howe, Sue Burrell, et al.
Pageof 2